Skip to main content
. 2013 Nov 12;14:249. doi: 10.1186/1471-2369-14-249

Table 2.

Percentages of incident hemodialysis and peritoneal dialysis patients with prescriptions for specific blood pressure medications at 6 months, by race/ethnicity, 2003–2008

 
Hemodialysis, n =12,159
Peritoneal dialysis, n = 913
Medication All Black White Other Hispanic All Black White Other Hispanic
n
 
4543
7075
541
679
 
256
607
50
33
None
12
10
13
13
11
10
8
10
xx
xx
Beta-blocker
 
 
 
 
 
 
 
 
 
 
  Any
59
60
59
58
55
55
54
55
56
42
  Alpha-beta
19
20
18
16
14
13
14
13
xx
xx
  Beta not alpha
41
40
41
42
41
42
40
42
44
30
RAS*
 
 
 
 
 
 
 
 
 
 
  Any
45
49
43
48
51
52
52
53
38
48
  ACEI
32
36
29
33
39
33
32
34
20
xx
  ARB
17
18
17
18
16
23
23
22
26
xx
CCB
 
 
 
 
 
 
 
 
 
 
  Any
49
57
43
49
55
50
55
37
50
45
  DHP
40
48
34
43
48
40
48
35
48
39
  Non-DHP
9
8
9
6
7
10
7
12
xx
xx
Diuretic
 
 
 
 
 
 
 
 
 
 
  Any
28
23
31
29
33
41
32
45
42
45
  Loop
26
21
29
26
32
38
31
42
36
42
  Thiazide
5
4
5
5
5
9
6
10
xx
xx
Alpha blocker
7
7
7
4
5
10
10
10
xx
xx
Central alpha 2 agonist
19
27
15
12
19
15
21
14
xx
xx
Hydralazine
8
10
7
5
9
4
6
3
xx
xx
Minoxidil 4 6 3 3 2 2 5 2 xx xx

Note: Values are percentages except for the n row, which represents numbers of patients.

ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker; DHP, dihydropyridine; RAS, renin angiotensin system agent.

*Renin-inhibitors comprised < 1% of RAS agents from 2003–2008.

Potassium-sparing diuretics comprised < 1% of diuretic agents from 2003–2008.

xx represents less than 10 persons per cell; these percentages have been suppressed.